Guggenheim Maintains Buy on Eli Lilly (LLY) After “Another Impressive Year”

Eli Lilly and Company (NYSE:LLY) is included among the 14 Best US Stocks to Buy for Long Term. Guggenheim Maintains Buy on Eli Lilly (LLY) After “Another Impressive Year” On December 3, Guggenheim raised its price target on Eli Lilly and Company (NYSE:LLY) to $1,163 from $1,036 and kept a Buy rating on the stock. The firm updated its models for LLY based on prescription trends and GLP-1 pricing news. While highlighting that the company “delivered another impressive year of stock performance in 2025,” the ...